Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mycosis Fungoides (MF)”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Early research (Phase 1)Study completedNCT02580552
What this trial is testing

Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL

Who this might be right for
Cutaneous T-cell Lymphoma (CTCL)Mycosis Fungoides (MF)Chronic Lymphocytic Leukemia (CLL)+2 more
miRagen Therapeutics, Inc. 66
Testing effectiveness (Phase 2)Ended earlyNCT01579318
What this trial is testing

Phase II Intratumoral IL12 Plasmid Electroporation in Cutaneous Lymphoma

Who this might be right for
Cutaneous T Cell Lymphomas (CTCL)Mycosis Fungoides (MF)
OncoSec Medical Incorporated 2
Not applicableActive Not RecruitingNCT05455931
What this trial is testing

Real World Observational Study of Poteligeo in Adult Patients With MF and SS (PROSPER)

Who this might be right for
Mycosis Fungoides and Sézary Syndrome
Kyowa Kirin Pharmaceutical Development Ltd 73
Not applicableStudy completedNCT02296164
What this trial is testing

Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma

Who this might be right for
Mycosis Fungoides
Helsinn Therapeutics (U.S.), Inc 300
Early research (Phase 1)UnknownNCT04118868
What this trial is testing

Pembrolizumab Administered Via the Sofusa® DoseConnect™ in Patients With Relapsed/Refractory Cutaneous T-cell Lymphoma.

Who this might be right for
Mycosis Fungoides
Sorrento Therapeutics, Inc. 10
Testing effectiveness (Phase 2)WithdrawnNCT03563040
What this trial is testing

Study of Photopheresis in the Treatment of Erythrodermic MF and SS

Who this might be right for
Lymphoma, T-Cell, CutaneousMycosis Fungoides/Sezary Syndrome
European Organisation for Research and Treatment of Cancer - EORTC
Early research (Phase 1)Active Not RecruitingNCT04652960
What this trial is testing

Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome

Who this might be right for
Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8
National Cancer Institute (NCI) 38
Testing effectiveness (Phase 2)Looking for participantsNCT04256018
What this trial is testing

Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome

Who this might be right for
Sezary SyndromeMycosis Fungoides
Stanford University 30
Testing effectiveness (Phase 2)Ended earlyNCT02341209
What this trial is testing

Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma

Who this might be right for
Cutaneous T-cell LymphomaMycosis FungoidesSezary Syndrome
Rochester General Hospital 1
Early research (Phase 1)WithdrawnNCT03617224
What this trial is testing

Pembrolizumab and Total Skin Electron Beam Radiotherapy in Mycosis Fungoides and Sézary Syndrome

Who this might be right for
Cutaneous T-Cell Lymphomas
University of Texas Southwestern Medical Center
Testing effectiveness (Phase 2)Study completedNCT00168064
What this trial is testing

Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides

Who this might be right for
Mycosis Fungoides
Yaupon Therapeutics 260
Not applicableStudy completedNCT05303480
What this trial is testing

Deep Phenotyping of Cutaneous T Cell Lymphoma, Type Mycosis Fungoides

Who this might be right for
Mycosis Fungoides
Centre for Human Drug Research, Netherlands 32
Testing effectiveness (Phase 2)Study completedNCT03380026
What this trial is testing

Mechlorethamine Induced Contact Dermatitis Avoidance Study

Who this might be right for
Cutaneous T-cell LymphomaCutaneous T-cell Lymphoma Stage IMycosis Fungoides+5 more
Rochester Skin Lymphoma Medical Group, PLLC 28
Testing effectiveness (Phase 2)Temporarily pausedNCT05138458
What this trial is testing

MT-101 in Subjects With CD5+ Relapsed/Refractory TCL

Who this might be right for
Lymphoma, T-Cell, PeripheralLymphoma, T-Cell, CutaneousMycosis Fungoides+2 more
Myeloid Therapeutics 40
Post-approval studies (Phase 4)Study completedNCT01007448
What this trial is testing

Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)

Who this might be right for
Refractory Cutaneous T-cell Lymphoma
Bausch Health Americas, Inc. 59
Testing effectiveness (Phase 2)Ended earlyNCT03837457
What this trial is testing

PRISM: Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Mycosis Fungoides Who Have Completed the SOLAR Study

Who this might be right for
Cutaneous T-Cell Lymphoma/Mycosis Fungoides
miRagen Therapeutics, Inc. 8
Testing effectiveness (Phase 2)Ended earlyNCT01187446
What this trial is testing

Low-dose (12 Gy) TSEBT+Vorinostat Versus Low-dose TSEBT Monotherapy in Mycosis Fungoides

Who this might be right for
Cutaneous LymphomaCutaneous T-cell Lymphoma
Stanford University 28
Not applicableWithdrawnNCT02301494
What this trial is testing

Effectiveness of Imiquimod Topical Cream in Early Stage Cutaneous T-cell Lymphoma

Who this might be right for
Mycosis Fungoides
Rochester General Hospital
Large-scale testing (Phase 3)Study completedNCT02448381
What this trial is testing

FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides)

Who this might be right for
Cutaneous T-Cell Lymphoma
Soligenix 169
Testing effectiveness (Phase 2)Ended earlyNCT00052377
What this trial is testing

Interleukin-12 and Interleukin-2 in Treating Patients With Mycosis Fungoides

Who this might be right for
Recurrent Cutaneous T-cell Non-Hodgkin LymphomaRecurrent Mycosis Fungoides/Sezary SyndromeStage I Cutaneous T-cell Non-Hodgkin Lymphoma+7 more
National Cancer Institute (NCI) 46
Load More Results